The microbiome and its impact on the epigenome in cancer
Frontiers in Epigenetics and Epigenomics · 17.06.2026 · 4
DOI: 10.3389/freae.2026.1857307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Epigenetics and Epigenomics, online erschienen am 17.06.2026. Verfasst von Akhil Kapoor und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medical Oncology, Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha …. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The complex interplay between the human microbiome and epigenetic regulation represents one of the most rapidly evolving frontiers in cancer biology. The trillions of microorganisms residing in and on the human body collectively termed the microbiota may influence the host gene expression through epigenetic mechanisms, including DNA methylation, histone modification, and non-coding RNA regulation. In cancer patients, is associated with disruption of the normal epigenetic landscape, contributing to oncogenesis, tumor progression, immune evasion, and therapeutic resistance. This review synthesizes current evidence on how specific microbial metabolites such as short-chain fatty acids, secondary bile acids, and folate derivatives modulate epigenetic marks in tumor cells and the tumor microenvironment. We further discuss the emerging concept of the “oncobiome” and examine how microbiome-epigenome crosstalk influences cancer risk, progression, and response to therapy including chemotherapy, immunotherapy, and epigenetic drugs. Finally, we explore the translational potential of microbiome modulation as an adjunct strategy in cancer epigenomics, highlighting key research gaps and future directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Medical Oncology, Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Varanasi, Uttar Pradesh, India.
- SVB Cancer Research Laboratory, Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Varanasi, Uttar Pradesh, India.
- Microbiome Domain, Leucine Rich Bio Pvt Ltd., Bengaluru, Karnataka, India.
- Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Zitieren
APA
Kapoor, A., Kumar, R., Gupta, A., Sansar, B., Mishra, B. K., Chaudhary, M., Rungta, A., Kallapura, G., & Prabhash, K. (2026). The microbiome and its impact on the epigenome in cancer. Frontiers in Epigenetics and Epigenomics, 4. https://doi.org/10.3389/freae.2026.1857307
Vancouver
Kapoor A, Kumar R, Gupta A, Sansar B, Mishra BK, Chaudhary M, et al. The microbiome and its impact on the epigenome in cancer. Frontiers in Epigenetics and Epigenomics. 2026;4. doi:10.3389/freae.2026.1857307
BibTeX
@article{Kapoor2026,
author = {Kapoor, Akhil and Kumar, Rohit and Gupta, Anuj and Sansar, Bipinesh and Mishra, Bal Krishna and Chaudhary, Mahesh and Rungta, Archi and Kallapura, Gopalakrishna and Prabhash, Kumar},
title = {The microbiome and its impact on the epigenome in cancer},
journal = {Frontiers in Epigenetics and Epigenomics},
year = {2026},
volume = {4},
doi = {10.3389/freae.2026.1857307}
}
EUVIMED